Cart 1 items $30.60
200pills.com
Search by name:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Highest drug quality
Shipping Worldwide
24/7 customer support
Best prices and bonuses!

TRY OUR ED PACKS

SAVE 20%

VIEW OUR ED PACKS PAGE


Your cart
Antabuse Antabuse 250 mg x 30 pills $ 30.60 $ 30.60
Update 30 pills to 60 pills and save $ 12.00
Shipping method:
$ 10.00  
Pay at our secure server: $ 40.60  
Our discount gifts for all reliable consumers:
10% Discount for all next orders 10% discount for all next orders
Free standard airmail service for all orders with sum starting at $200.00 Free standard airmail service for all orders with sum starting at $200
Testimonials
Peter, Wien
I have tried Viagra and Cialis before and must say that Levitra causes less side effects though. I had terrible headache with Viagra which made sex impossible sometimes. With Levitra I forgot about it. I would recommend it to anybody who has similar problems ...
read more»
Barbara Smith, Ansonia, United States
I AM SO SORRY TO HAVE DOUBTED YOUR SERVICE. I RECEIVED A NOTICE FROM THE POST OFFICE ON FRIDAY 11/4, THAT A REG. MAIL FROM YOU WAS THERE. I WILL BE RECEIVING THE PACKAGE TODAY. THANK YOU SO MUCH FOR ALL YOUR ASSISTANCE AND AGAIN I APOLOGIZE FOR NOT HAVING ...
read more»
News
Could RFK Jr's move to pull mRNA vaccine funding be a huge miscalculation?
The US is withdrawing $500m for vaccines for diseases like flu and Covid. Health correspondent James Gallagher asks if it's the right call.
Union and government to restart talks on ending doctor dispute
BMA says there is window of opportunity in coming weeks to reach a settlement after 12 strikes.
RFK Jr cancels $500m in funding for mRNA vaccines for diseases like Covid
Since taking office, the vaccine sceptic has made a number of changes to how vaccines are regulated.
Obesity jab patients need a plan to stop weight coming back, health experts say
Patients coming off Wegovy or Mounjaro should have support and advice for at least a year afterwards, NHS told.
Shipping Option

Sitemap
Subscribe to the news